Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia

Circulation

Volumn 126, Issue 25, 2012, Pages 2990-2999

  Herse, Florian ^a   Lamarca, Babbette ^b   Hubel, Carl A ^c   Kaartokallio, Tea ^d   Lokki, A Inkeri ^d   Ekholm, Eeva ^e   Laivuori, Hannele ^d   Gauster, Martin ^f   Huppertz, Berthold ^f   Sugulle, Meryam ^g,h   Ryan, Michael J ^b   Novotny, Sarah ^b   Brewer, Justin ^b   Park, Joon Keun ⁱ   Kacik, Michael ^j   Hoyer, Joachim ^j   Verlohren, Stefan ^k   Wallukat, Gerd ^a   Rothe, Michael ^l   Luft, Friedrich C ^a   Muller, Dominik N ^m   Schunck, Wolf Hagen ^a   Staff, Anne C ^g,h   Dechend, Ralf ^a,n   more..

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY OF OSLO   (Norway)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j PHILIPPS UNIVERSITY MARBURG   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l LIPIDOMIX GMBH   (Germany)

^m UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁿ HELIOS KLINIKUM BERLIN BUCH   (Germany)

more..

Author keywords

cytochrome P450; hypertension; preeclampsia; pregnancy

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; AMIDE; ANGIOTENSIN II; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYTOCHROME P450 2J2; DIHYDROXYICOSATRIENOIC ACID; N (METHYLSULFONYL) 2 (2 PROPYNYLOXY) BENZENEHEXANAMIDE; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DECIDUA; GESTATIONAL AGE; HEART MUSCLE CELL; HEART RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIPOGENESIS; MICROARRAY ANALYSIS; NONHUMAN; PLACENTA; PLACENTA CIRCULATION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST; UPREGULATION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; HYDRAZINES; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84871346041     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.127340     Document Type: Article

References (46)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365: 785-799.
2. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682-2689.
3. Llinas MT, Alexander BT, Capparelli MF, Carroll MA, Granger JP. Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats. Hypertension. 2004;43:623-628.
4. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women withpre-eclampsia. BrJ Obstet Gynaecol. 1995;102: 20-25.
5. Sunderland NS, Thomson SE, Heffernan SJ, Lim S, Thompson J, Ogle R, McKenzie P, Kirwan PJ, Makris A, Hennessy A. Tumor necrosis factor a induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine. 2011;56:192-199.
6. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294:H541-H550.
7. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123:2856-2869.
8. Luksha L, Luksha N, Kublickas M, Nisell H, Kublickiene K. Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia. Biol Reprod. 2010;83:728-735.
9. Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachido-nate monooxygenase. J Lipid Res. 2000;41:163-181.
10. Balazy M. Metabolism of 5, 6-epoxyeicosatrienoic acid by the human platelet: formation of novel thromboxane analogs. J Biol Chem. 1991; 266:23561-23567.
11. Catella F, Lawson JA, Fitzgerald DJ, FitzGerald GA. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci USA. 1990;87: 5893-5897.
12. Schafer WR, Zahradnik HP, Arbogast E, Wetzka B, Werner K, Breckwoldt M. Arachidonate metabolism in human placenta, fetal membranes, decidua and myometrium: lipoxygenase and cytochrome P450 metabolites as main products in HPLC profiles. Placenta. 1996;17: 231-238.
13. Zhang JH, Pearson T, Matharoo-Ball B, Ortori CA, Warren AY, Khan R, Barrett DA. Quantitative profiling of epoxyeicosatrienoic, hydroxyeico- satetraenoic, and dihydroxyeicosatetraenoic acids in human intrauterine tissues using liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem. 2007;365:40-51.
14. Staff AC, Ranheim T, Khoury J, Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol. 1999;180:587-592.
15. McCormick J, Whitley GS, Le Bouteiller P, Cartwright JE. Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. Hum Reprod. 2009;24:1339-1345.
16. Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A, von Schacky C, Luft FC, Muller DN, Rothe M, Schunck WH Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of to-3 fatty acids. J Biol Chem. 2010;285:32720-32733.
17. Wallukat G, Neichel D, Nissen E, Homuth V, Luft FC. Agonistic auto-antibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Can J Physiol Pharmacol. 2003;81:79-83.
18. Kohler R, Degenhardt C, Kuhn M, Runkel N, Paul M, Hoyer J. Expression and function of endothelial Ca(2 +)-activated K(+) channels in human mesenteric artery: a single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ. Circ Res. 2000;87:496-503.
19. Llinas MT, Alexander BT, Seedek M, Abram SR, Crell A, Granger JP. Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats. Am J Hypertens. 2002;15:793-797.
20. Hering L, Herse F, Geusens N, Verlohren S, Wenzel K, Staff AC, Brosnihan KB, Huppertz B, Luft FC, Muller DN, Pijnenborg R, Cart-wright JE, Dechend R. Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hypertension. 2010;56:311-318.
21. Verlohren S, Niehoff M, Hering L, Geusens N, Herse F, Tintu AN, Plagemann A, LeNoble F, Pijnenborg R, Muller DN, Luft FC, Duden-hausen JW, Gollasch M, Dechend R. Uterine vascular function in a transgenic preeclampsia rat model. Hypertension. 2008;51:547-553.
22. Pijnenborg R, McLaughlin PJ, Vercruysse L, Hanssens M, Johnson PM, Keith JC Jr, Van Assche FA. Immunolocalization of tumour necrosis factor-a (TNF-a) in the placental bed of normotensive and hypertensive human pregnancies. Placenta. 1998;19:231-239.
23. Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem. 1996;271: 3460-3468.
24. Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, Markovic N, Thadhani R, Luft FC, Dechend R. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 2007;49:612-617.
25. Zhou Y, Chang HH, Du J, Wang CY, Dong Z, Wang MH. Renal epoxyeicosatrienoic acid synthesis during pregnancy. Am J Physiol Renal Physiol. 2005;288:F221-F226.
26. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-a blockade. Hypertension. 2008;52:1161-1167.
27. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131-185.
28. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 2007;292:C996-C1012.
29. Campbell WB, Fleming I. Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch. 2010;459:881-895.
30. Konkel A, Schunck WH. Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochim Biophys Acta. 2011; 1814:210-222.
31. Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009;8:794-805.
32. Huang H, Chang HH, Xu Y, Reddy DS, Du J, Zhou Y, Dong Z, Falck JR, Wang MH. Epoxyeicosatrienoic acid inhibition alters renal hemodynam-ics during pregnancy. Exp Biol Med (Maywood). 2006;231:1744-1752.
33. Nithipatikom K, Gross GJ. Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection. J Cardiovasc Pharmacol Ther. 2010;15:112-119.
34. Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ. Epoxyeicosanoid signaling in CNS function and disease. Prostaglandins Other Lipid Mediat. 2010;91:68-84.
35. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285:1276-1279.
36. Yang B, Graham L, Dikalov S, Mason RP, Falck JR, Liao JK, Zeldin DC. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol. 2001;60:310-320.
37. Kanasaki K, Kalluri R. The biology of preeclampsia. Kidney Int. 2009; 76:831-837.
38. Lee SB, Wong AP, Kanasaki K, Xu Y, Shenoy VK, McElrath TF, Whitesides GM, Kalluri R. Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol. 2010;176:710-720.
39. Suzuki S, Oguro A, Osada-Oka M, Funae Y, Imaoka S. Epoxyeicosatrienoic acids and/or their metabolites promote hypoxic response of cells. J Pharmacol Sci. 2008;108:79-88.
40. Spiecker M, Liao JK. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys. 2005;433: 413-420.
41. Zosmer A, Elder MG, Sullivan MH. The regulation of arachidonic acid metabolism in human first trimester trophoblast by cyclic AMP. Prostaglandins Other Lipid Mediat. 2003;71:43-53.
42. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest. 1998;101:464-470.
43. Wenzel K, Rajakumar A, Haase H, Geusens N, Hubner N, Schulz H, Brewer J, Roberts L, Hubel CA, Herse F, Hering L, Qadri F, Lindschau C, Wallukat G, Pijnenborg R, Heidecke H, Riemekasten G, Luft FC, Muller DN, Lamarca B, Dechend R. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58:77-84.
44. Fernandez-Fernandez JM, Tomas M, Vazquez E, Orio P, Latorre R, Senti M, Marrugat J, Valverde MA. Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension. J Clin Invest. 2004;113:1032-1039.
45. Kohler R. Single-nucleotide polymorphisms in vascular Ca2 +-activated K +-channel genes and cardiovascular disease. Pflugers Arch. 2010;460: 343-351.
46. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(suppl A):S32-S37.